Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-response of Verosudil in Glaucoma/OHT
NCT01699464Phase 2Completed
- Sponsor
- Aerie Pharmaceuticals
- Start
- Oct 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of verosudil in open-angle glaucoma (OAG), ocular hypertension, sponsored by Aerie Pharmaceuticals. Started Oct 2012; status: completed.
02
Drugs
verosudil
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT01699464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01699464.